High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study

Loretta J. Nastoupil, Peter McLaughlin, Lei Feng, Sattva S. Neelapu, Felipe Samaniego, Fredrick B. Hagemeister, Ana Ayala, Jorge E. Romaguera, Andre H. Goy, Eleanor Neal, Michael Wang, Luis Fayad, Michelle A. Fanale, Yasuhiro Oki, Jason R. Westin, Maria A. Rodriguez, Fernando Cabanillas, Nathan H. Fowler

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study'. Together they form a unique fingerprint.

Medicine & Life Sciences